Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

CXCL13 is a plasma biomarker of germinal center activity

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Havenar-Daughton, C.
  • Lindqvist, M.
  • Heit, A.
  • Wu, J. E.
  • Reiss, S. M.
  • Kendric, K.
  • Belanger, S.
  • Kasturi, S. P.
  • Landais, Elise
  • Akondy, R. S.
  • McGuire, H. M.
  • Bothwell, M.
  • Vagefi, P. A.
  • Scully, E.
  • Tomaras, G. D.
  • Davis, M. M.
  • Poignard, Pascal
  • Ahmed, R.
  • Walker, B. D.
  • Pulendran, B.
  • McElrath, M. J.
  • Kaufmann, D. E.
  • Crotty, S.

publication date

  • March 2016

journal

  • Proceedings of the National Academy of Sciences of the United States of America  Journal

abstract

  • Significantly higher levels of plasma CXCL13 [chemokine (C-X-C motif) ligand 13] were associated with the generation of broadly neutralizing antibodies (bnAbs) against HIV in a large longitudinal cohort of HIV-infected individuals. Germinal centers (GCs) perform the remarkable task of optimizing B-cell Ab responses. GCs are required for almost all B-cell receptor affinity maturation and will be a critical parameter to monitor if HIV bnAbs are to be induced by vaccination. However, lymphoid tissue is rarely available from immunized humans, making the monitoring of GC activity by direct assessment of GC B cells and germinal center CD4(+) T follicular helper (GC Tfh) cells problematic. The CXCL13-CXCR5 [chemokine (C-X-C motif) receptor 5] chemokine axis plays a central role in organizing both B-cell follicles and GCs. Because GC Tfh cells can produce CXCL13, we explored the potential use of CXCL13 as a blood biomarker to indicate GC activity. In a series of studies, we found that plasma CXCL13 levels correlated with GC activity in draining lymph nodes of immunized mice, immunized macaques, and HIV-infected humans. Furthermore, plasma CXCL13 levels in immunized humans correlated with the magnitude of Ab responses and the frequency of ICOS(+) (inducible T-cell costimulator) Tfh-like cells in blood. Together, these findings support the potential use of CXCL13 as a plasma biomarker of GC activity in human vaccine trials and other clinical settings.

subject areas

  • Animals
  • Biomarkers
  • Chemokine CXCL13
  • Cohort Studies
  • Enzyme-Linked Immunosorbent Assay
  • Flow Cytometry
  • Germinal Center
  • HIV Infections
  • Humans
  • Lymph Nodes
  • Macaca
  • Mice, Inbred C57BL
  • Vaccination
scroll to property group menus

Research

keywords

  • CXCL13
  • HIV
  • Tfh
  • antibodies
  • vaccines
scroll to property group menus

Identity

PubMed Central ID

  • PMC4790995

International Standard Serial Number (ISSN)

  • 0027-8424

Digital Object Identifier (DOI)

  • 10.1073/pnas.1520112113

PubMed ID

  • 26908875
scroll to property group menus

Additional Document Info

start page

  • 2702

end page

  • 2707

volume

  • 113

issue

  • 10

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support